2022
DOI: 10.3390/curroncol29120721
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of Women Who Could Benefit from Hormone Therapy after Endometrial Cancer Treatment: An Analysis of SEER Data

Abstract: Our primary aim was to estimate the magnitude of stage I endometrial cancer (EC) survivors that could benefit from hormonal therapy (HT). Our secondary aims were to assess EC incidence in women below 50 and below 60 over the years, and analyze the overall survival and any influencing factors. We analyzed the endometrioid EC data from the Surveillance, Epidemiology, and End Results (SEER) program according to women’s age, tumor stage, and grade. We analyzed the proportions of EC survivors below 50 and below 60 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
(45 reference statements)
0
1
0
Order By: Relevance
“…We utilized information from the Surveillance, Epidemiology, and End Results (SEER) program, the United States National Center for Health Statistics as part of the National Vital Statistics System, the United Nations Population Division, the GLOBOCAN Cancer Observatory, the CLIO-INFRA project database, the Human Fertility Database, as well as anonymized local data. The SEER compiles cancer incidence and survival data from cancer registries covering approximately 34.6% of the U.S. population [ 6 ]. The National Vital Statistics System collects birth data from every state and territory in the United States [ 7 ].…”
Section: Methodsmentioning
confidence: 99%
“…We utilized information from the Surveillance, Epidemiology, and End Results (SEER) program, the United States National Center for Health Statistics as part of the National Vital Statistics System, the United Nations Population Division, the GLOBOCAN Cancer Observatory, the CLIO-INFRA project database, the Human Fertility Database, as well as anonymized local data. The SEER compiles cancer incidence and survival data from cancer registries covering approximately 34.6% of the U.S. population [ 6 ]. The National Vital Statistics System collects birth data from every state and territory in the United States [ 7 ].…”
Section: Methodsmentioning
confidence: 99%